| P50 | author | Orson W Moe | Q87611844 |
| | Khashayar Sakhaee | Q124681188 |
| | Giovanni Gambaro | Q52677855 |
| | Daniel G Fuster | Q57010595 |
| | Ita Pfeferman Heilberg | Q67189767 |
| | David S. Goldfarb | Q42403463 |
| P2093 | author name string | Gary C Curhan | |
| | Kemal Sarica | |
| | Noor Buchholz | |
| | Roswitha Siener | |
| | James C Williams | |
| | Pasquale Strazzullo | |
| | Dawn Milliner | |
| | Pietro Manuel Ferraro | |
| | John Lieske | |
| | Martino Marangella | |
| | James Lingeman | |
| | Fredric Coe | |
| | David Bushinsky | |
| | Emanuele Croppi | |
| | Consensus Conference Group | |
| | Glen M Preminger | |
| | Bernard Hess | |
| | Elen Worcester | |
| | Jose' Manuel Reis Santos | |
| P2860 | cites work | Predictive value of kidney stone composition in the detection of metabolic abnormalities | Q44515991 |
| | Outcome of metabolic evaluation and medical treatment for calcium nephrolithiasis in a private urological practice | Q44686649 |
| | Biochemical and physicochemical presentations of patients with brushite stones | Q44758740 |
| | Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II. | Q44865341 |
| | Allopurinol and calcium-stone formers | Q44885035 |
| | Clinical value of crystalluria study | Q45009024 |
| | The effect of fruits and vegetables on urinary stone risk factors | Q45166244 |
| | Peculiar morphology of stones in primary hyperoxaluria | Q46506012 |
| | 24-h uric acid excretion and the risk of kidney stones | Q46866036 |
| | Effect of potential renal acid load of foods on urinary citrate excretion in calcium renal stone formers | Q46902860 |
| | The effect of calcium channel blockers on stone regrowth and recurrence after shock wave lithotripsy | Q46931633 |
| | Chronic kidney disease in kidney stone formers | Q24617170 |
| | Do kidney stone formers have a kidney disease? | Q26786273 |
| | Medical management of kidney stones: AUA guideline | Q28240681 |
| | Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis | Q28254324 |
| | Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up | Q28296597 |
| | Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) | Q29618529 |
| | Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxy apatite, brushite, or calcium oxalate stones | Q33582212 |
| | In idiopathic calcium oxalate stone-formers, unattached stones show evidence of having originated as attached stones on Randall's plaque | Q33596321 |
| | FT-IR analysis of urinary stones: a helpful tool for clinician comparison with the chemical spot test. | Q33608573 |
| | Risk factors for CKD in persons with kidney stones: a case-control study in Olmsted County, Minnesota | Q33616302 |
| | Metabolic evaluation of first-time and recurrent stone formers | Q33737379 |
| | Unravelling the links between calcium excretion, salt intake, hypertension, kidney stones and bone metabolism | Q33992398 |
| | Diet and risk of kidney stones in the Oxford cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC). | Q34040676 |
| | Hereditary causes of kidney stones and chronic kidney disease | Q34066169 |
| | Clinical study on the effect of mineral waters containing bicarbonate on the risk of urinary stone formation in patients with multiple episodes of CaOx-urolithiasis | Q79858901 |
| | Oxalate intake and the risk for nephrolithiasis | Q80406342 |
| | Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III | Q81324759 |
| | Quality control in urinary stone analysis: results of 44 ring trials (1980-2001) | Q81671636 |
| | The Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study: nephrolithotomy in 189 patients with solitary kidneys | Q82058954 |
| | Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial | Q82370043 |
| | [The role of thiazides in the prophylaxis of recurrent calcium lithiasis] | Q83912206 |
| | The relationship between calcium kidney stones, arterial stiffness and bone density: unraveling the stone-bone-vessel liaison | Q85650090 |
| | Papillary calcifications: a new prognostic factor in idiopathic calcium oxalate urolithiasis | Q86485567 |
| | Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis | Q93578439 |
| | Allopurinol treatment of uric-acid disorders in calcium-stone formers | Q93731306 |
| | Composition and structure of urinary stone | Q44193277 |
| | Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions | Q44288956 |
| | Validation of Randall's plaque theory using unenhanced abdominal computed tomography | Q44349561 |
| | Conversion of calcium oxalate to calcium phosphate with recurrent stone episodes | Q44456778 |
| | Urolithiasis through the ages. | Q34125173 |
| | Impact of nutritional factors on incident kidney stone formation: a report from the WHI OS. | Q34193603 |
| | Long-term treatment with potassium citrate and renal stones in medullary sponge kidney | Q34281561 |
| | Urolithiasis and the risk of ESRD. | Q34284900 |
| | Distinguishing characteristics of idiopathic calcium oxalate kidney stone formers with low amounts of Randall's plaque | Q34292839 |
| | Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline | Q34336412 |
| | Soda and other beverages and the risk of kidney stones | Q34344824 |
| | Incomplete distal renal tubular acidosis from a heterozygous mutation of the V-ATPase B1 subunit | Q34439794 |
| | Calcium plus vitamin D supplementation and the risk of fractures | Q34495055 |
| | Thiazide diuretics, potassium, and the development of diabetes: a quantitative review | Q34542023 |
| | The ROKS nomogram for predicting a second symptomatic stone episode | Q34568756 |
| | Knowledge, attitudes, and practice patterns among healthcare providers in the prevention of recurrent kidney stones in Northern Ontario | Q34602128 |
| | Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts | Q34662070 |
| | Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones | Q34673925 |
| | A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones | Q34730506 |
| | Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study | Q34732675 |
| | Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women | Q34738989 |
| | Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle | Q34834615 |
| | Determinants of osteopenia in male renal-stone-disease patients with idiopathic hypercalciuria. | Q34927100 |
| | Nephrolithiasis-associated bone disease: pathogenesis and treatment options | Q34936324 |
| | Brushite stone disease as a consequence of lithotripsy? | Q35202298 |
| | Profile of the brushite stone former | Q35214756 |
| | Plaque and deposits in nine human stone diseases | Q35220482 |
| | Kidney stones are common after bariatric surgery | Q35243688 |
| | Dietary calcium from dairy and nondairy sources, and risk of symptomatic kidney stones | Q35373518 |
| | Mechanism by which shock wave lithotripsy can promote formation of human calcium phosphate stones | Q35436905 |
| | Biopsy proven medullary sponge kidney: clinical findings, histopathology, and role of osteogenesis in stone and plaque formation. | Q35514473 |
| | CKD and Its Risk Factors among Patients with Cystinuria | Q35576095 |
| | Fluid intake and epidemiology of urolithiasis | Q35610081 |
| | Renal stone analysis: why and how? | Q35693345 |
| | The Vacuolar H+-ATPase B1 Subunit Polymorphism p.E161K Associates with Impaired Urinary Acidification in Recurrent Stone Formers | Q35802404 |
| | Chlorthalidone improves vertebral bone quality in genetic hypercalciuric stone-forming rats | Q35825152 |
| | Kidney stones and kidney function loss: a cohort study | Q36201055 |
| | Fracture risk among patients with urolithiasis: a population-based cohort study. | Q50908960 |
| | Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. | Q51002792 |
| | Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects. | Q51527459 |
| | Composition and morphology of phosphate stones and their relation with etiology. | Q51536268 |
| | Physiological effects of slow release potassium phosphate for absorptive hypercalciuria: a randomized double-blind trial. | Q51568304 |
| | Renal acidification defects in patients with their first renal stone episode. | Q51627232 |
| | Randomized trial of allopurinol in the prevention of calcium oxalate calculi. | Q52870729 |
| | Renal function in patients with nephrolithiasis. | Q53593994 |
| | Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. | Q53637438 |
| | The melatonin receptor 1A (MTNR1A) gene is associated with recurrent and idiopathic calcium nephrolithiasis. | Q54366871 |
| | Double-blind study with thiazide in recurrent calcium lithiasis | Q57228325 |
| | Renal histopathology of stone-forming patients with distal renal tubular acidosis | Q62630729 |
| | Effect of oral purine load and allopurinol on the crystallization of calcium salts in urine of patients with hyperuricosuric calcium urolithiasis | Q67401635 |
| | Placebo versus allopurinol for renal calculi | Q67587883 |
| | Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not | Q68130766 |
| | Soft drink consumption and urinary stone recurrence: a randomized prevention trial | Q68196520 |
| | Successful management of uric acid nephrolithiasis with potassium citrate | Q69668176 |
| | Unprocessed bran and intermittent thiazide therapy in prevention of recurrent urinary calcium stones | Q69822780 |
| | Calcium crystalluria in recurrent renal-stone formers | Q70111592 |
| | Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients | Q70303959 |
| | Thiazide prophylaxis of urolithiasis. A double-blind study in general practice | Q70359850 |
| | Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy | Q71223074 |
| | Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences | Q71608795 |
| | Cross-over study of the influence of bicarbonate-rich mineral water on urinary composition in comparison with sodium potassium citrate in healthy male subjects | Q73437915 |
| | Citrate determines calcium oxalate crystallization kinetics and crystal morphology-studies in the presence of Tamm-Horsfall protein of a healthy subject and a severely recurrent calcium stone former | Q73487565 |
| | Sustained reduction in urinary calcium during long-term treatment with slow release neutral potassium phosphate in absorptive hypercalciuria | Q74468445 |
| | Agglomeration inhibition reflected stone-forming activity during long-term potassium citrate therapy in calcium stone formers | Q77628602 |
| | A prospective study of nonmedical prophylaxis after a first kidney stone | Q78196175 |
| | Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria | Q36314974 |
| | Determinants of 24-hour urinary oxalate excretion | Q36843498 |
| | Current computed tomography techniques can detect duct of Bellini plugging but not Randall's plaques | Q37097426 |
| | Intra-tubular deposits, urine and stone composition are divergent in patients with ileostomy | Q37191601 |
| | Phenotypic characterization of kidney stone formers by endoscopic and histological quantification of intrarenal calcification | Q37200980 |
| | Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease | Q37208998 |
| | Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time | Q37290751 |
| | DASH-style diet associates with reduced risk for kidney stones | Q37367687 |
| | Bone disease in patients with primary hypercalciuria and calcium nephrolithiasis | Q37475818 |
| | Relevance of Mediterranean diet and glucose metabolism for nephrolithiasis in obese subjects | Q37580584 |
| | Micro-computed tomography for analysis of urinary calculi | Q37802241 |
| | Applications of dual-energy CT in urologic imaging: an update | Q38002233 |
| | When to suspect a genetic disorder in a patient with renal stones, and why. | Q38071852 |
| | Randall's plaques, plugs and the clinical workup of the renal stone patient | Q38237312 |
| | Inaccurate reporting of mineral composition by commercial stone analysis laboratories: implications for infection and metabolic stones. | Q38274036 |
| | A Proposed Grading System to Standardize the Description of Renal Papillary Appearance at the Time of Endoscopy in Patients with Nephrolithiasis | Q38274757 |
| | Acceptance of mixed scientific and clinical activities in a sub-speciality urology meeting | Q39036240 |
| | Heterogeneous Nucleation with Urate, Calcium Phosphate and Calcium Oxalate | Q39123761 |
| | Crystalluria in Normal Subjects and in Stone Formers With and Without Thiazide and Cellulose Phosphate Treatment | Q39135911 |
| | Mechanism for calcium urolithiasis among patients with hyperuricosuria: supersaturation of urine with respect to monosodium urate | Q39137209 |
| | Urinary Calcium Excretion in Human Beings | Q39258890 |
| | Effect of potassium citrate on bone density, microarchitecture, and fracture risk in healthy older adults without osteoporosis: a randomized controlled trial | Q39518177 |
| | Crystal-associated nephropathy in patients with brushite nephrolithiasis. | Q39706235 |
| | Renal crystal deposits and histopathology in patients with cystine stones. | Q39755764 |
| | Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones | Q39844900 |
| | Hypercalciuria and Hyperuricosuria in Patients with Calcium Nephrolithiasis | Q39948733 |
| | Sodium Urate Accelerates Precipitation of Calcium Oxalate In Vitro | Q40344585 |
| | Heterogeneous Nucleation of Calcium Oxalate by Seeds of Monosodium Urate | Q40344588 |
| | Dissolved urate salts out calcium oxalate in undiluted human urine in vitro: implications for calcium oxalate stone genesis | Q40596772 |
| | Urinary calculi: review of classification methods and correlations with etiology. | Q40734904 |
| | Calcium phosphate stone morphology can reliably predict distal renal tubular acidosis | Q41603962 |
| | Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder | Q41970406 |
| | The effect of preincubation of seed crystals of uric acid and monosodium urate with undiluted human urine to induce precipitation of calcium oxalate in vitro : implications for urinary stone formation | Q42146961 |
| | Ascorbic acid supplements and kidney stone incidence among men: a prospective study | Q43599458 |
| | Hyperuricosuric calcium oxalate nephrolithiasis | Q43661660 |
| | Vegetable consumption and risk of chronic disease | Q43692018 |
| | Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria | Q43850214 |
| | Risk of chronic and end stage kidney disease in patients with nephrolithiasis | Q43903524 |
| | Stone screening and follow-up are necessary? | Q44061161 |
| | Crystal agglomeration is a major element in calcium oxalate urinary stone formation | Q44071761 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | calcium | Q706 |
| | inorganic compound | Q190065 |
| | secondary prevention | Q2839152 |
| | diagnosis | Q16644043 |
| | nephrolithiasis | Q18557037 |
| | preventive health services | Q65732032 |
| | biomedical investigative technique | Q66648976 |
| P1104 | number of pages | 20 | |
| P304 | page(s) | 715-734 | |
| P577 | publication date | 2016-07-25 | |
| | 2016-12-01 | |
| P1433 | published in | Journal of Nephrology | Q15765408 |
| P1476 | title | Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement | |
| P478 | volume | 29 | |